文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒性休克时肾素-血管紧张素系统的改变

Alterations in the renin-angiotensin system during septic shock.
PubMed 文献 · Ann Intensive Care · 2025-03-24
一句话结论脓毒性休克患者相比健康对照,Ang I/Ang II与Ang-(1-7)/Ang II比值升高,cACE活性降低、cACE2活性与cDPP3浓度升高。

这项前瞻性单中心对照研究纳入20例符合Sepsis-3脓毒性休克诊断的患者和30例对照,用液相色谱-质谱法测定血浆中经典与替代RAAS肽段平衡浓度,并检测循环ACE、ACE2活性及cDPP3浓度,主要时间点为诊断后6小时。结果显示脓毒性休克患者Ang I、Ang-(1-7)等主要肽段浓度升高,Ang I/Ang II比值(1.16 [0.74-3.31] vs. 0.34 [0.25-0.43],p < 0.05)和Ang-(1-7)/Ang II比值(0.15 [0.08-1.30] vs. 0.03 [0.02-0.04],p < 0.05)显著升高;cACE活性降低(3.38 [2.29-6.8] vs. 7.89 [6.39-9.05] nmol Ang II/L/h),cACE2活性升高(814 [669-1987] vs. 214 [132-293] pmol Ang-(1-7)/L/h),cDPP3浓度升高(54.6 [35-142.2] ng/mL vs. 13.7 [11.9-15.4] ng/mL),均p < 0.05。这些改变提示脓毒性休克时RAAS通路失衡,可能为 angiotensin II 等靶向治疗提供病理生理依据。

要点

  • 脓毒性休克患者诊断后6小时Ang I/Ang II比值高于健康对照:1.16 [0.74-3.31] vs. 0.34 [0.25-0.43],p < 0.05。
  • 脓毒性休克患者Ang-(1-7)/Ang II比值高于健康对照:0.15 [0.08-1.30] vs. 0.03 [0.02-0.04],p < 0.05。
  • 脓毒性休克患者cACE活性低于对照:3.38 [2.29-6.8] vs. 7.89 [6.39-9.05] nmol Ang II/L/h,p < 0.05。
  • 脓毒性休克患者cACE2活性高于对照:814 [669-1987] vs. 214 [132-293] pmol Ang-(1-7)/L/h,p < 0.05。
  • 脓毒性休克患者cDPP3浓度高于对照:54.6 [35-142.2] ng/mL vs. 13.7 [11.9-15.4] ng/mL,p < 0.05。

适用人群与场景

  • 20例符合Sepsis-3脓毒性休克诊断的患者,以及30例健康对照。
  • 排除使用任何既往改变RAAS的药物、既往肝衰竭(Child-Pugh评分 > 9)或慢性肾脏病(估算肾小球滤过率 < 30 ml/min/1.73 m²)的患者。

诊断标准与关键阈值

  • 脓毒性休克诊断依据Sepsis-3标准。

研究设计与关键结果

  • 研究类型:前瞻性、单中心、对照研究;样本量:20例脓毒性休克患者和30例对照;主要时间点:诊断后6小时,与30例对照比较。
  • 脓毒性休克患者经典与替代RAAS主要肽段浓度升高,尤其是Ang I和Ang-(1-7)。
  • Ang I/Ang II比值:脓毒性休克组1.16 [0.74-3.31] vs. 对照组0.34 [0.25-0.43],p < 0.05。
  • Ang-(1-7)/Ang II比值:脓毒性休克组0.15 [0.08-1.30] vs. 对照组0.03 [0.02-0.04],p < 0.05。
  • cACE活性:脓毒性休克组3.38 [2.29-6.8] vs. 对照组7.89 [6.39-9.05] nmol Ang II/L/h,p < 0.05。
  • cACE2活性:脓毒性休克组814 [669-1987] vs. 对照组214 [132-293] pmol Ang-(1-7)/L/h,p < 0.05。
  • cDPP3浓度:脓毒性休克组54.6 [35-142.2] ng/mL vs. 对照组13.7 [11.9-15.4] ng/mL,p < 0.05。

证据类型、等级与局限

  • 证据类型:前瞻性、单中心、对照研究。
  • 局限:原文未报告局限性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Alterations in the classical Renin-Angiotensin Aldosterone System (RAAS) have been described during septic shock and are associated with patient outcomes. Since the alternative RAAS has also been reported to be altered in critically ill patients, and given that the RAAS can be modulated by specific therapeutics, such as angiotensin II, understanding its pathophysiology is of primary interest.

OBJECTIVE: To describe the alterations in the classical and alternative RAAS during septic shock in comparison with healthy controls.

METHODS: This prospective, monocentric, controlled study enrolled 20 patients fulfilling the septic shock diagnosis, as defined by the Sepsis-3 criteria, along with 30 controls. The main exclusion criteria were the use of any prior medication modifying the RAAS, prior liver failure (Child-Pugh score > 9), or chronic kidney disease (estimated glomerular filtration rate < 30 ml/min/1.73 m²). Equilibrium concentrations of RAAS peptides were analyzed using a liquid chromatography-mass spectrometry method from heparinized plasma. Circulating angiotensin-converting enzyme (cACE), cACE type 2 (cACE2) activities, and circulating dipeptidyl peptidase 3 (cDPP3) concentrations were assessed. Values were measured at diagnosis, 6 h after diagnosis and on days 1 and 3. The main timepoint of interest was 6 h after diagnosis. Values 6 h after diagnosis were compared to 30 controls.

RESULTS: In septic shock patients, increased concentrations of the main peptides of the classical and alternative RAAS were observed compared to controls, particularly angiotensin I (Ang I) and angiotensin-(1-7) (Ang-(1-7)). Additionally, there was a significant increase in the Ang I/Ang II ratio (1.16 [0.74-3.31] vs. 0.34 [0.25-0.43], p < 0.05) and the Ang-(1-7)/Ang II ratio (0.15 [0.08-1.30] vs. 0.03 [0.02-0.04], p < 0.05). We also observed a significant reduction in cACE activity (3.38 [2.29-6.8] vs. 7.89 [6.39-9.05] nmol Ang II/L/h), an increase in cACE2 activity (814 [669-1987] vs. 214 [132-293] pmol Ang-(1-7)/L/h), and increased cDPP3 concentrations (54.6 [35-142.2] ng/mL vs. 13.7 [11.9-15.4] ng/mL, all p < 0.05).

CONCLUSIONS: Septic shock was associated with increased Ang I/Ang II and Ang-(1-7)/Ang II ratios, along with reduced cACE activity, increased cACE2 activity, and elevated cDPP3 concentrations compared to healthy controls.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Benaroua C, Pucci F, Rooman M, et al. Alterations in the renin-angiotensin system during septic shock. Ann Intensive Care. 2025. PMID: 40126750. doi:10.1186/s13613-025-01463-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。